Advertisement
Advertisement

XAIR

XAIR logo

Beyond Air Inc

0.4495
USD
-0.0055
-1.21%
Dec 18, 15:53 UTC -5
Closed
...

Beyond Air Inc Profile

About

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden City, New York.

Info & Links

CEO

Steven Lisi

Headquarters

900 STEWART AVENUE, SUITE 301
GARDEN CITY, NY 11530, UNITED STATES

Auditor

Marcum LLP

Share holders

105

Employees

107

Beyond Air Inc Statistics

Valuation Measures

Market Capitalization2

32.45M

Enterprise Value

14.97M

Enterprise Value/EBITDA(ttm)

-0.29

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

14.33

Price to Book(mrq)

0.75

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-96.21%

Operating Margin(ttm)

-2369.17%

Profit Margin(ttm)

-2631.26%

Return on Equity(ttm)

-227.29%

Return on Invested Capital(ttm)

-155.19%

Return on Assets(ttm)

-106.51%

Income Statement

Revenue(ttm)

2.34M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

-2.29M

EBITDA(ttm)3

-51.33M

Net Income Available to Common(ttm)

-55.49M

Diluted EPS(ttm)

-1.41

Share Statistics

Beta (5Y Monthly)

-0.23

52-Week Change

-71.00%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

57.68M

% Held by Insiders

20.10%

% Held by Institutions

31.50%

Balance Sheet

Total Cash(mrq)

28.68M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

11.20M

Total Debt/Equity(mrq)

38.23%

Current Ratio(mrq)

5.76%

Quick Ratio(mrq)

5.38%

Book Value Per Share(mrq)

0.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.50

Free Cash Flow(ytd)

-27.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement